Defining optimal immunotherapies for type 1 diabetes
Saved in:
| Corporate Author: | |
|---|---|
| Other Authors: | , |
| Format: | Book |
| Published: |
Chichester
Wiley-Blackwell
2008
|
| Series: | Novartis Foundation symposium
|
| Subjects: | |
| Online Access: | Click Here to View Status and Holdings. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Add Tag MARC
| LEADER | 00000n a2200000 a 4501 | ||
|---|---|---|---|
| 001 | wils-446020 | ||
| 020 | # | # | |a 9780470723258 |
| 020 | # | # | |a 0470723254 |
| 020 | # | # | |a 9780470519004 |
| 020 | # | # | |a 0470519002 |
| 040 | # | # | |a DNLM |d ITMB |
| 090 | 0 | 0 | |a WK815 |b S9895d 2008 |
| 111 | 1 | # | |a Symposium on Defining Optimal Immunotherapies for Type 1 Diabetes |c London, England) |d (2007 |
| 245 | 1 | 0 | |a Defining optimal immunotherapies for type 1 diabetes |c [editors, Gregory Bock and Jamie Goode] |
| 260 | # | # | |a Chichester |b Wiley-Blackwell |c 2008 |
| 300 | # | # | |a ix, 212 p. |b ill. |c 23 cm |
| 490 | 1 | # | |a Novartis Foundation symposium |v 292 |
| 500 | # | # | |a Papers from the Novartis Foundation Symposium on Defining optimal immunotherapies for type 1 diabetes, held at The Novartis Foundation, London, 11-12 July 2007 |
| 504 | # | # | |a Includes bibliographical references and indexes |
| 650 | # | 0 | |a Diabetes Mellitus, Type 1 |x therapy |
| 700 | 1 | # | |a Bock, Gregory |
| 700 | # | # | |a Goode, Jamie |
| 830 | # | 1 | |a Novartis Foundation symposium |
| 856 | 4 | 0 | |z Click Here to View Status and Holdings. |u https://opac.uitm.edu.my/opac/detailsPage/detailsHome.jsp?tid=446020 |
| 964 | # | # | |c BOK |d HS |
Diabetes